These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 3805366)
1. Premature epiphyseal closure--a complication of etretinate therapy in children. Prendiville J; Bingham EA; Burrows D J Am Acad Dermatol; 1986 Dec; 15(6):1259-62. PubMed ID: 3805366 [TBL] [Abstract][Full Text] [Related]
2. Etretinate therapy in children with severe keratinization defects. Traupe H; Happle R Eur J Pediatr; 1985 Jan; 143(3):166-9. PubMed ID: 2580708 [TBL] [Abstract][Full Text] [Related]
3. Etretinate and premature epiphyseal closure in children. Glover MT; Atherton DJ J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):853-4. PubMed ID: 3680668 [No Abstract] [Full Text] [Related]
4. [Rheumatologic effects of etretinate]. Cuny JF; Schmutz JL; Terver MN; Aussedat R; Cointin M; Weber M; Beurey J Ann Dermatol Venereol; 1989; 116(2):95-102. PubMed ID: 2660711 [TBL] [Abstract][Full Text] [Related]
5. [Bone complications from chronic etretinate intoxication in children]. Cointin M; Sommelet-Olive D; Cuny JF; Bretagne MC Ann Pediatr (Paris); 1990 Sep; 37(7):458-60. PubMed ID: 2256641 [TBL] [Abstract][Full Text] [Related]
6. Etretinate (Tigason) for skin disease. Drug Ther Bull; 1983 Feb; 21(3):9-11. PubMed ID: 6839967 [No Abstract] [Full Text] [Related]
7. Bone changes in children on long-term treatment with etretinate. Halkier-Sørensen L; Laurberg G; Andresen J J Am Acad Dermatol; 1987 May; 16(5 Pt 1):999-1006. PubMed ID: 3584585 [TBL] [Abstract][Full Text] [Related]
8. Bone changes and their significance in children with ichthyosis on long-term etretinate therapy. Paige DG; Judge MR; Shaw DG; Atherton DJ; Harper JI Br J Dermatol; 1992 Oct; 127(4):387-91. PubMed ID: 1419759 [TBL] [Abstract][Full Text] [Related]
9. Treatment of systematized verrucous epidermal naevus by aromatic retinoid (Ro. 10-9359). Abdel-Aal MA Clin Exp Dermatol; 1983 Nov; 8(6):647-50. PubMed ID: 6661828 [No Abstract] [Full Text] [Related]
10. Surveillance for skeletal toxicity of children treated with etretinate. Glover MT; Peters AM; Atherton DJ Br J Dermatol; 1987 May; 116(5):609-14. PubMed ID: 3297126 [TBL] [Abstract][Full Text] [Related]
11. [Bone changes in long-term therapy with etretinate (Tigason)]. Haustein UF; Heilmann S Z Hautkr; 1987 Mar; 62(5):395-6, 399-400. PubMed ID: 3590912 [TBL] [Abstract][Full Text] [Related]
12. An appraisal of acitretin therapy in children with inherited disorders of keratinization. Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418 [TBL] [Abstract][Full Text] [Related]
13. [Epidermal verrucous linear inflammatory hamartoma (3 cases)]. Jellouli A; Kourda M; Souissi R; Ben Rhomdane K Tunis Med; 1993 Dec; 71(12):595-9. PubMed ID: 8134963 [No Abstract] [Full Text] [Related]
14. [Skeletal changes caused by etretinate]. Crespi HG; Massimo JA; Gentile F; Cordero AA Med Cutan Ibero Lat Am; 1986; 14(2):77-81. PubMed ID: 3528712 [TBL] [Abstract][Full Text] [Related]
15. [Growth behavior after epiphyseal plate injury: importance of "watertight" osteosynthesis]. von Laer L Unfallchirurg; 2014 Dec; 117(12):1071-84. PubMed ID: 25421326 [TBL] [Abstract][Full Text] [Related]
16. Partial improvement of Olmsted syndrome with etretinate. Ueda M; Nakagawa K; Hayashi K; Shimizu R; Ichihashi M Pediatr Dermatol; 1993 Dec; 10(4):376-81. PubMed ID: 8302745 [TBL] [Abstract][Full Text] [Related]